Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-18-1090
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

EZH2 as a Therapeutic Target in Solid Tumors

Cancer Cell & Microenvironment
2015English

EZH2 as a Therapeutic Target for Multiple Myeloma and Other Haematological Malignancies

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2018English

Synthetic Genetic Array Screen Identifies PP2A as a Therapeutic Target in Mad2-Overexpressing Tumors

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Kinase Inhibitor Screening Identifies CDK4 as a Potential Therapeutic Target for Melanoma

International Journal of Oncology
Cancer ResearchOncology
2015English

EZH2 in Bladder Cancer, a Promising Therapeutic Target

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2015English

Systematic Approach Identifies RHOA as a Potential Biomarker Therapeutic Target for Asian Gastric Cancer

Oncotarget
Oncology
2016English

Functional Characterization of Human Polycomb-Like 3 Isoforms Identifies Them as Components of Distinct EZH2 Protein Complexes

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2011English

Analysis of Oncogenic Signaling Networks in Glioblastoma Identifies ASPM as a Molecular Target

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

EGFR Family Inhibition Identifies P38 MAPK as a Potential Therapeutic Target in Bladder Cancer

Urology
Urology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy